A01K 2227/10
Mammal
A01K2227/10 (Mammal) appears on 3,935 US grants and 7,848 published applications in this corpus.
Search patents in A01K- Granted patents
- 3,935
- Published applications
- 7,848
- Assignees
- 2,403
- Inventors
- 13,019
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 2 | 0 |
| 1992 | 6 | 0 |
| 1993 | 4 | 0 |
| 1994 | 7 | 0 |
| 1995 | 10 | 0 |
| 1996 | 38 | 0 |
| 1997 | 64 | 0 |
| 1998 | 99 | 0 |
| 1999 | 104 | 0 |
| 2000 | 99 | 0 |
| 2001 | 113 | 22 |
| 2002 | 74 | 236 |
| 2003 | 107 | 778 |
| 2004 | 76 | 264 |
| 2005 | 60 | 291 |
| 2006 | 111 | 327 |
| 2007 | 135 | 242 |
| 2008 | 132 | 241 |
| 2009 | 120 | 247 |
| 2010 | 132 | 280 |
| 2011 | 111 | 260 |
| 2012 | 114 | 197 |
| 2013 | 112 | 212 |
| 2014 | 112 | 204 |
| 2015 | 142 | 248 |
| 2016 | 130 | 261 |
| 2017 | 154 | 263 |
| 2018 | 150 | 272 |
| 2019 | 156 | 357 |
| 2020 | 165 | 416 |
| 2021 | 184 | 420 |
| 2022 | 168 | 449 |
| 2023 | 187 | 393 |
| 2024 | 194 | 396 |
| 2025 | 207 | 351 |
| 2026 | 152 | 221 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Non-human animals having humanized Fc-gamma receptors29 Sep 2026US 12,745,761 B2Regeneron Pharmaceuticals, Inc.
- Genetically modified non-human animal with human or chimeric TFR122 Sep 2026US 12,740,550 B2Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
- Methods of treating rheumatoid arthritis using RNA-guided genome editing of HLA gene22 Sep 2026US 12,742,179 B2National Jewish Health
- Non-canonical SWI/SNF complex and uses thereof8 Sep 2026US 12,729,225 B2Dana-Farber Cancer Institute, Inc.
- Rat models for CMT2A that develop a progressive neuropathy1 Sep 2026US 12,721,327 B2Charcot-Marie-Tooth Association
- Transgenic model of human cardiomyopathy8 Oct 2026US 2026/0305586 A1Stichting Genetische Hartspierziekte PLN
- Humanized ace2-expressing transgenic mouse susceptible to sars-cov-2 virus infection and method for producing same8 Oct 2026US 2026/0305587 A1Seoul National University R&Db Foundation
- Genetically Modified Non-Human Animals and Methods of Use Thereof8 Oct 2026US 2026/0305588 A1Institute for Research in Biomedicine (IRB)
- Compositions and methods for delivery of immune cells to treat un-resectable or non-resected tumor cells and tumor relapse8 Oct 2026US 2026/0308532 A1Fred Hutchinson Cancer Center
- Feed intake monitoring device and system based on pressure sensing during cattle jaw movement1 Oct 2026US 2026/0293857 A1Information Technology Research Center, Beijing Academy of Agriculture and Forestry Sciences
Most cited
By later US patents
- Ransgenic non-human animals for producing heterologous antibodies1,941US 5,545,806 AGenPharm International, Inc. · 1996
- Transgenic non-human animals capable of producing heterologous antibodies of various isotypes1,748US 5,569,825 AGenPharm International, Inc. · 1996
- Transgenic non-human animals capable of producing heterologous antibodies1,680US 5,633,425 AGenPharm International, Inc. · 1997
- Transgenic non-human animals for producing heterologous antibodies1,604US 5,625,126 AGenPharm International, Inc. · 1997
- Production of antibodies from transgenic animals1,567US 5,545,807 AMedical Research Council · 1996